Dopamine Agonists (adverse effects) And NotWarner H. Poewe
List of bibliographic references
Number of relevant bibliographic references: 7.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000211 | Fanny Pineau [France] ; Michael Schüpbach [France] ; Jean-Christophe Corvol [France] ; Constance Flamand-Rouvière [France] ; Marie Vidailhet [France] ; Emmanuel Roze [France] | Long‐standing paraphilia induced by dopamine agonists in Parkinson's disease |
| 000223 | Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database |
| 000429 | Olivier Rascol [France] ; Atul Pathak [France] ; Haleh Bagheri [France] ; Jean-Louis Montastruc [France] | New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance |
| 000435 | Olivier Rascol [France] ; Atul Pathak [France] ; Haleh Bagheri [France] ; Jean-Louis Montastruc [France] | Dopaminagonists and fibrotic valvular heart disease: Further considerations |
| 000506 | Jean-Louis Montastruc [France] ; Olivier Rascol [France] | Modafinil and pramipexole‐associated somnolence |
| 000518 | Jean-Louis Montastruc [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
| 000557 | P. Damier [France] ; C. Jaillon [France] ; I. Clavier [France] ; I. Arnulf [France] ; A.-M. Bonnet [France] ; B.-P. Bejjani [France] ; Yves Agid [France] | Dyskinesias assessment in phase II studies |
| This area was generated with Dilib version V0.6.23. |  |